Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions


Latest Cancer News

Breast cancer treatment with fewer potential side effects has equally good patient outcomes, UCLA study shows (July 2, 2015)

A new study by UCLA scientists has found that women diagnosed with breast cancer and treated with a one-week regimen of partial breast radiation after the surgical removal of the tumor, or lumpectomy,... Continue Reading

New Drug Combination Boosts Survival in Advanced Stomach and Esophageal Cancers (July 1, 2015)

Patients whose metastatic stomach or esophageal cancers were driven by a mutated HER2 gene had markedly improved response rates and survival when bevacizumab (Avastin) was added to a standard drug combination.... Continue Reading

Rintega® Improves Survival in Patients with Glioblastoma Multiforme (July 1, 2015)

The immunotherapy drug Rintega® (rindopepimut) appears to improve survival among patients with relapsed glioblastoma multiforme (GBM) brain cancer. These findings were presented at 2015 Annual Meeting... Continue Reading

Better Outcomes in Oral Cancer with Surgery to Remove Lymph Nodes in Neck before Cancer Spreads (June 30, 2015)

In early squamous-cell oral cancer, surgery to remove lymph nodes in the neck before cancer spreads may result in better outcomes. These findings were presented at 2015 Annual Meeting of the American Society... Continue Reading

Opdivo® Alone or Combined with Yervoy® Effective in Advanced Melanoma (June 29, 2015)

Opdivo® (nivolumab) used alone or in combination with Yervoy® (ipilimumab) appears to extend progression-free survival in patients with advanced melanoma. These findings were presented at 2015 Annual... Continue Reading

Aetna Provides Coverage for Biodesix’ VeriStrat Test (June 25, 2015)

Biodesix, Inc. announced that its VeriStrat® test is now considered a medically necessary benefit by Aetna Corporation (NYSE: AET).  Aetna published a positive coverage policy for the VeriStrat proteomic... Continue Reading

“Boosted” Radiation Dose May Make Some Pancreatic Cancers Resectable (June 24, 2015)

Because of its location, cancers on the pancreas may invade and wrap around nearby veins and arteries in the abdomen. When these vessels become involved, surgery to remove the cancer, which is typically... Continue Reading

New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment (June 23, 2015)

Metastatic colorectal cancer patients tend to live longer when they respond to the first line of chemotherapy their doctors recommend. To better predict how patients will respond to chemotherapy drugs... Continue Reading

New Targeted Drug Offers Promising Treatment Option in Resistant EGFR-Positive Lung Cancers (June 22, 2015)

Patients with lung cancer driven by a mutation in the EGFR gene frequently respond well to inhibitors that block the mutation’s activity. But eventually, those cancers become resistant to the inhibitor... Continue Reading

New Drug Combination Extends Survival of Patients with Metastatic Colorectal Cancer (June 18, 2015)

A drug developed 50 years ago and abandoned because it was considered to be too toxic has gained a second life in an international clinical trial. Research led by scientists at Dana-Farber Cancer Institute... Continue Reading

BCM Study Findings Show That a Mother’s Diet Before Pregnancy May Affect Her Child’s Lifelong Cancer Risk (June 17, 2015)

A collaborative team of international researchers led by Dr. Robert Waterland, PhD, associate professor of pediatrics and nutrition at Baylor College of Medicine (BCM) and the USDA/ARS Children’s Nutrition... Continue Reading

Coming Soon: Lynch Syndrome: Get the Facts (June 15, 2015)

Ask the Experts Series: A Family Affair: When Cancer Runs in the Family Lynch Syndrome: Get the Facts about this Hereditary Cancer Syndrome   CancerConnect announces the opportunity to engage with... Continue Reading

Drug Rucaparib Promising in Pretreated BRCA-Positive Ovarian Cancer (June 15, 2015)

The drug rucaparib appears active in women with recurrent BRCA-positive ovarian cancer that has progressed after previous treatment. These findings were presented at 2015 Annual Meeting of the American... Continue Reading

Longer Overall Survival for Patients with Soft Tissue Sarcoma Treated with Halaven® (June 11, 2015)

Halaven® (eribulin) may extend overall survival in patients with previously treated, advanced soft tissue sarcoma (STS). These findings were presented at 2015 Annual Meeting of the American Society of... Continue Reading

MD Anderson Researchers Show Risks of Whole Brain Radiation Therapy Added to Radiosurgery Outweigh Benefits In Patients With Limited Brain Metastases (June 10, 2015)

Radiation oncology researchers from The University of Texas MD Anderson Cancer Center (MD Anderson CC), presented results from a Phase III randomized clinical trial studying the effects of Whole Brain... Continue Reading

Arimidex® More Effective than Tamoxifen in Prevention of Recurrence in Early Breast Cancer (June 9, 2015)

For patients with a common type of breast cancer known as ductal carcinoma in situ (DCIS), the drug Arimidex® (anastrozole) may provide better protection against recurrence than tamoxifen. These findings... Continue Reading

Keytruda® Promising in Advanced Head and Neck Cancer (June 8, 2015)

The immunotherapy Keytruda® (pembrolizumab) appears active in the treatment of advanced squamous cell head and neck cancer. These findings were presented at 2015 Annual Meeting of the American Society... Continue Reading

Phase III Study Confirms Benefits of Lenalidomide Maintenance Therapy for Patients with Multiple Myeloma (June 4, 2015)

BUFFALO, N.Y. — A large cooperative-group study directed by the Alliance for Clinical Trials in Oncology has confirmed previous evidence that the drug lenalidomide delays time to disease progression... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions

Cancer Types

Headline News by Cancer Type

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS